GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adbiotech Co Ltd (XKRX:179530) » Definitions » Cash Flow from Discontinued Operations

Adbiotech Co (XKRX:179530) Cash Flow from Discontinued Operations : ₩0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Adbiotech Co Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Adbiotech Co's cash flow from discontinued operations for the three months ended in Mar. 2024 was ₩0 Mil. It means Adbiotech Co received ₩0 Mil from the sale of part of business quarterly. Adbiotech Co's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0 Mil.

Adbiotech Co Cash Flow from Discontinued Operations Historical Data

The historical data trend for Adbiotech Co's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adbiotech Co Cash Flow from Discontinued Operations Chart

Adbiotech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Discontinued Operations
- - - - -

Adbiotech Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Adbiotech Co Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adbiotech Co Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Adbiotech Co's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Adbiotech Co (XKRX:179530) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adbiotech Co Ltd (XKRX:179530) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
XKRX:343090 XKRX:950220 XKRX:283100 XKRX:322970 XKRX:208340 XKRX:215380 XKRX:344860 XKRX:446440 XKRX:456190 XKRX:251280 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
39, Geodudanji 1-gil, Dongnae-myeon, Gangwon-do, Chuncheon, KOR, 24398
Website
http://www.adbiotech.com
Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.

Adbiotech Co (XKRX:179530) Headlines

No Headlines